Scott Tozier
Analyst · Nomura Instinet. Please go ahead
Thanks Luke, and good morning. In the first quarter, we reported adjusted net income of $1.05 per diluted share, an increase of 13% compared to the first quarter of 2016, excluding the year-over-year net impact of divested businesses. The increase was driven by an adjusted EBITDA increase of $35 million or about $0.24 per share from our three GBUs. Business results were countered by about $0.12 per share of negative impact from the combination of corporate costs, foreign exchange, tax, D&A and interest expense. As Luke noted, our $250 million accelerated share buyback program is well underway. At this point, we have estimate the buyback will result in an average diluted share count for the full year of 2017 of about 112.1 million shares. We continue to expect our 2017 effective tax rate, excluding special items, non-operating pension and OPEB items to be approximately 22%. Capital spending in the first quarter was $54 million with significant commitments executed for major equipment and services for our wave one lithium projects. As construction activities progress and equipment deliveries are made over the course of 2017, the spending rate will increase. We still expect total 2017 spending of $350 million to $400 million. Corporate costs in the first quarter were $32 million driven by compensation costs and negative currency exchange impacts. We do not expect the first quarter spending rate continue, but given first quarter costs and our updated view on the rest of the year, 2017 corporate costs are now expected to range from $95 million to $105 million. Operating working capital ended the first quarter at 27% of revenue in line with our 2017 guidance, and we expect to remain at a similar level through the rest of the year. Adjusted free cash flow in the first quarter was strong at $76 million. For the full year, we continue to expect adjusted free cash flow of $200 million to $300 million with the expected ramp-up in capital spending impacting the rest of 2017. And finally, currency exchange rates compared to 2016 negatively impacted adjusted EBITDA by $5 million in the first quarter. We currently forecast a negative full year adjusted EBITDA impact of $10 million to $15 million compared to 2016. The primary impact both in the quarter and in the full year forecast is from the euro. Our 2016 average rate was just over €1.1 per the U.S. dollar, and we currently forecast €1.06 for 2017. Now let me turn to our business units. Lithium and Advanced Materials had another strong quarter led by the Lithium business. First quarter net sales of $284 million increased by 32% compared to first quarter of 2016. While adjusted EBITDA of $120 million was 39% higher than first quarter of 2016, adjusted EBITDA margins were strong at 42%. Lithium had another outstanding quarter, with first quarter net sales of 58% and adjusted EBITDA of 56% compared to the first quarter of 2016. Adjusted EBITDA margins were 46%, above our long-term expectations of the low-40s for this business. Volume growth for the first quarter was 39% with pricing up 21%. Battery-grade products drove essentially all of the volume growth and most of the pricing improvement. Most of the volume growth came from our recently acquired spodumene conversion assets, but we also continue to utilize total conversion as well. Also La Negra II in Chile began initial commercial production with a strong ramp expected as 2017 progresses. We are pleased with the initial performance of our new spodumene conversion assets in China. Production rates in the first quarter were outstanding and operations at both sides are undergoing rapid integration with the rest of Albemarle. We are already utilizing Albemarle systems to manage and report production activities, and most back-office functions are running through our regional shared services center. The capital project to expand production by 28,000 to 25,000 metric tons of lithium hydroxide at the [indiscernible] site is already underway. Compared to the first quarter of 2016, PCS sales were down $11 million and adjusted EBITDA was down $2 million. Weakness in our [indiscernible] and catalysts and organic metallics businesses and impact from the SunEdison bankruptcy was partially offset by initial results from our cost savings program and stronger year-over-year performance in curatives. Bromine Specialties’ first quarter sales of $219 million and adjusted EBITDA of $68 million were up by 12% and 11%, respectively, compared to the first quarter of 2016. Increased demand for flame retardants across various electronic applications was a major driver of sales growth, but we also benefited from sales improvement in elemental bromine and specialty bromine derivatives. High operating rates and continued productivity improvements in manufacturing also contributed to the year-over-year improvement. First quarter adjusted EBITDA margins of 31% were over 300 basis points above the 2016 average of 28%. While it is still early, we are encouraged by the favorable trends we saw in bromine in 2016 and have continued in the first few months of 2017. Refining Solutions reported first quarter net sales of $185 million and adjusted EBITDA of $50 million. Compared to the first quarter of 2016, sales were up 9% and adjusted EBITDA was down 10%. Fluid catalytic cracking, or FCC Catalysts, and clean fused technologies, or HPC Catalysts, contributed by an equally to sales growth. FCC sales increases were driven by strong demand in North America while solid demand globally, especially in the heavier feed resid segment drove HPC revenues. Adjusted EBITDA was down as expected driven by the impact of customer turnarounds and competitive trials at FCC, less favorable product mix in CFT and higher input costs. Now I’ll turn the call back over to Luke to update our 2017 outlook.